MiMedx Group
MDXG
150 hedge funds and large institutions have $290M invested in MiMedx Group in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 18 closing their positions.
160% more call options, than puts
Call options by funds: $1.17M | Put options by funds: $449K
1.48% more ownership
Funds ownership: 53.31% → 54.79% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 44
1% less funds holding
Funds holding: 152 → 150 (-2)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
19% less capital invested
Capital invested by funds: $360M → $290M (-$69.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.13M |
| 2 |
BMO
Beck Mack & Oliver
New York
|
+$2.67M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.22M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$879K |
| 5 |
Renaissance Technologies
New York
|
+$656K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$2.44M |
| 2 |
RI
RTW Investments
New York
|
-$1.79M |
| 3 |
CP
Castleview Partners
Dallas,
Texas
|
-$1.04M |
| 4 |
Citigroup
New York
|
-$734K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$497K |
MDXG Hedge Fund Activity: Q1 2022 in Review
150 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q1 2022, worth a combined $290M — down 19% from $360M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of MDXG and 16 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 42 added.
The largest buyer was Federated Hermes, adding an estimated $8.13M. The largest seller was Brown Advisory, cutting an estimated $2.44M.
- 150 institutional investors held MiMedx Group (MDXG) as of Q1 2022, down from 152 in Q4 2021.
- Funds reported $290M of MiMedx Group stock for Q1 2022, down 19% quarter-over-quarter.
- 16 funds opened new MiMedx Group positions in Q1 2022 and 18 closed out, a net change of -2 holders.
- The largest MiMedx Group buyer in Q1 2022 was Federated Hermes, an estimated $8.13M added.
- The largest MiMedx Group seller in Q1 2022 was Brown Advisory, an estimated $2.44M sold.
Based on aggregated 13F filings for Q1 2022.